Congenital thrombotic thrombocytopenic purpura: Atypical presentation and new ADAMTS 13 mutation in a tunisian child

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 5, Issue 1, 2013, Pages 1-3

  Borgi, A ^a   Khemiri, M ^a   Veyradier, A ^b   Kazdaghli, K ^a   Barsaoui, S ^a  

^a UNIVERSITY OF TUNIS   (Tunisia)

^b NICU Clamart Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; FRESH FROZEN PLASMA; HEMOGLOBIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADAMTS 13 GENE; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; CHILD; FEVER; GENE MUTATION; GENETIC ANALYSIS; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; MALE; PRESCHOOL CHILD; PROTEINURIA; PURPURA; RETICULOCYTOSIS; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; BLOOD CLOTTING TEST; CLINICAL FEATURE; DISEASE DURATION; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENZYME ACTIVITY; ENZYME DEFICIENCY; EXON; FOLLOW UP; HEMOLYTIC ANEMIA; KIDNEY FUNCTION; LABORATORY TEST; MICROANGIOPATHY; PHYSICAL EXAMINATION; PLASMA TRANSFUSION; SCHISTOCYTE; SEQUENCE ANALYSIS; TREATMENT OUTCOME; TUNISIAN;

EID: 84890481488     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/MJHID.2013.041     Document Type: Article

References (10)

1. Barbot J, Costa E, Guerra M et al . Ten years of prophylactic treatment with fresh-frozen plasma in a child with chronic relapsing thrombotic thrombocytopenic purpura as a result of a congenital deficiency of von Willebrand factor-cleaving protease. Br J Haematol. 2001;113(3):649-51. http://dx.doi.org/10.1046/j.1365-2141.2001.02808.xPMid:11380451
2. Veyradier A, Lavergne JM, Ribba AS et al. Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome). J Thromb Haemost. 2004;2(3):424-9. http://dx.doi.org/10.1111/j.1538-7933.2004.00623.xPMid:15009458
3. Suddour H, Rouabah M, Mansuy L,Bordigonie P, Hascoet JM. Thrombotic thrombocytopenic purpura in a newborn. Arch pediatr.2007; 14(1):39-42.
4. Loirat C, Girma JP, Desconclois C, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children. Pediatr Nephrol. 2009;24(1):19-29. http://dx.doi.org/10.1007/s00467-008-0863-5PMid:18574602
5. Schneppenheim R, Budde U, Oyen F et al. Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP. Blood. 2003;101(5):1845-50. http://dx.doi.org/10.1182/blood-2002-08-2399PMid:12393505
6. Studt JD, Kremer Hovinga JA, Antoine G et al. Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. Blood. 2005;105(2):542-4. http://dx.doi.org/10.1182/blood-2004-06-2096PMid:15367436
7. Alford S L, Harrisson P , Lawrie AS, Liesner R, Mackie IJ, Machin SJ. Von willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. Br J Haematol. 2000;111(4):1215-22. http://dx.doi.org/10.1046/j.1365-2141.2000.02503.x
8. Just S. Methodologies and clinical utility of ADAMTS-13 activity testing. Semin Thromb Hemost. 2010;36(1):82-90. http://dx.doi.org/10.1055/s-0030-1248727PMid:20391299
9. Boukedi A, Chabchoub Ben Abdallah R, Ben Salah M. Le syndrome hémolytique et urémique atypique chez l'enfant. Arch Pédiatr. 2010;17(6 suppl1):31-2. http://dx.doi.org/10.1016/S0929-693X(10)70331-6
10. Meyer SC, Jeddi R, Meddeb B, Guider E, Lammle B, Kremer Hovinga JA. The first case of congenital TTPon the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13. Ann Hematol.2008; 87(8):663-6. http://dx.doi.org/10.1007/s00277-008-0496-6PMid:18443791